MM patients exhibiting CD64 expression on mNs equal to or higher than 15 standard deviations from the mean value detected in HDs were included in the MM2 (CD64high) group; patients with mN CD64 expression below this level were included in the MM1 (CD64low) group (Figures 1B, C). This evidence concerns the gene FCGR1A and Miyoshi myopathy.